Literature DB >> 25991041

C4d as a Diagnostic Tool in Proliferative GN.

Sanjeev Sethi1, Samih H Nasr2, An S De Vriese3, Fernando C Fervenza4.   

Abstract

Proliferative GN is classified as immune complex-mediated or complement-mediated (C3 glomerulopathy). Immune complex-mediated GN results from glomerular deposition of immune-complexes/Ig and C3; the C3 is derived from activation of the classical and/or lectin pathways of complement. C3 glomerulopathy results from deposition of C3 and other complement fragments with minimal or no deposition of immune complexes/Ig; the C3 is derived from activation of the alternative pathway of complement. C4d is a byproduct of activation of the classic and lectin pathways. Although widely used as a marker for antibody-mediated rejection, the significance of C4d in C3 glomerulopathy is undetermined. We studied glomerular C4d staining in 18 biopsy specimens of immune-complex GN, 30 biopsy specimens of C3 GN, and 13 biopsy specimens of postinfectious GN. All specimens of immune complex-mediated GN, except two specimens of IgA nephropathy and one specimen of sclerosing membranoproliferative GN, showed bright (2-3+) C4d staining. The staining pattern of C4d mirrored the staining patterns of Ig and C3. Conversely, C4d staining was completely negative in 24 (80%) of 30 specimens of C3 glomerulopathy, and only trace/1+ C4d staining was detected in six (20%) specimens. With regard to postinfectious GN, C4d staining was negative in six (46%) of 13 specimens, suggesting an abnormality in the alternative pathway, and it was positive in seven (54%) specimens. To summarize, C4d serves as a positive marker for immune complex-mediated GN but is absent or minimally detected in C3 glomerulopathy.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  glomerulonephritis; immunology and pathology; kidney biopsy; membranoproliferative glomerulonephritis (MPGN); renal pathology

Mesh:

Substances:

Year:  2015        PMID: 25991041      PMCID: PMC4625660          DOI: 10.1681/ASN.2014040406

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  33 in total

1.  Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis.

Authors:  I Ohsawa; H Ohi; M Endo; T Fujita; M Matsushita; T Fujita
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

2.  Is cellular C4d a good biomarker for SLE nephritis?

Authors:  V Dhir
Journal:  Lupus       Date:  2012-04-02       Impact factor: 2.911

Review 3.  Membranoproliferative glomerulonephritis--a new look at an old entity.

Authors:  Sanjeev Sethi; Fernando C Fervenza
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

4.  Redefining C3 glomerulopathy: 'C3 only' is a bridge too far.

Authors:  Christopher P Larsen; Patrick D Walker
Journal:  Kidney Int       Date:  2013-02       Impact factor: 10.612

5.  C3 glomerulonephritis associated with monoclonal gammopathy: a case series.

Authors:  Ladan Zand; Andrea Kattah; Fernando C Fervenza; Richard J H Smith; Samih H Nasr; Yuzhou Zhang; Julie A Vrana; Nelson Leung; Lynn D Cornell; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2013-04-26       Impact factor: 8.860

6.  C3 nephritic factor associated with C3 glomerulopathy in children.

Authors:  Camille Nicolas; Vincent Vuiblet; Veronique Baudouin; Marie-Alice Macher; Isabele Vrillon; Nathalie Biebuyck-Gouge; Maud Dehennault; Sophie Gié; Denis Morin; Hubert Nivet; François Nobili; Tim Ulinski; Bruno Ranchin; Maria Chiarra Marinozzi; Stéphanie Ngo; Véronique Frémeaux-Bacchi; Christine Pietrement
Journal:  Pediatr Nephrol       Date:  2013-09-26       Impact factor: 3.714

7.  Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.

Authors:  Min-Kyung Kim; Young-In Maeng; Sun-Jae Lee; In Hee Lee; Jisuk Bae; Yu-Na Kang; Byung-Tae Park; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

8.  Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Ladan Zand; Nicole C Meyer; Nicolò Borsa; Samih H Nasr; Richard J H Smith
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

9.  C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.

Authors:  Sanjeev Sethi; Fernando C Fervenza; Yuzhou Zhang; Ladan Zand; Julie A Vrana; Samih H Nasr; Jason D Theis; Ahmet Dogan; Richard J H Smith
Journal:  Kidney Int       Date:  2012-08       Impact factor: 10.612

10.  C3 glomerulopathy: consensus report.

Authors:  Matthew C Pickering; Vivette D D'Agati; Carla M Nester; Richard J Smith; Mark Haas; Gerald B Appel; Charles E Alpers; Ingeborg M Bajema; Camille Bedrosian; Michael Braun; Mittie Doyle; Fadi Fakhouri; Fernando C Fervenza; Agnes B Fogo; Véronique Frémeaux-Bacchi; Daniel P Gale; Elena Goicoechea de Jorge; Gene Griffin; Claire L Harris; V Michael Holers; Sally Johnson; Peter J Lavin; Nicholas Medjeral-Thomas; B Paul Morgan; Cynthia C Nast; Laure-Hélène Noel; D Keith Peters; Santiago Rodríguez de Córdoba; Aude Servais; Sanjeev Sethi; Wen-Chao Song; Paul Tamburini; Joshua M Thurman; Michael Zavros; H Terence Cook
Journal:  Kidney Int       Date:  2013-10-30       Impact factor: 10.612

View more
  40 in total

1.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Authors:  Sanjeev Sethi; Mark Haas; Glen S Markowitz; Vivette D D'Agati; Helmut G Rennke; J Charles Jennette; Ingeborg M Bajema; Charles E Alpers; Anthony Chang; Lynn D Cornell; Fernando G Cosio; Agnes B Fogo; Richard J Glassock; Sundaram Hariharan; Neeraja Kambham; Donna J Lager; Nelson Leung; Michael Mengel; Karl A Nath; Ian S Roberts; Brad H Rovin; Surya V Seshan; Richard J H Smith; Patrick D Walker; Christopher G Winearls; Gerald B Appel; Mariam P Alexander; Daniel C Cattran; Carmen Avila Casado; H Terence Cook; An S De Vriese; Jai Radhakrishnan; Lorraine C Racusen; Pierre Ronco; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 2.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

Review 3.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

4.  C4d Staining in the Diagnosis of C3 Glomerulopathy.

Authors:  H Terence Cook
Journal:  J Am Soc Nephrol       Date:  2015-05-19       Impact factor: 10.121

5.  C4d deposits in IgA nephropathy: where does complement activation come from?

Authors:  Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

Review 6.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

7.  Complement Detection in Mouse Kidneys by Immunofluorescence.

Authors:  Jennifer Laskowski; Joshua M Thurman
Journal:  Methods Mol Biol       Date:  2021

Review 8.  All Things Complement.

Authors:  Joshua M Thurman; Carla M Nester
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

Review 9.  Antibody-mediated complement activation in pathology and protection.

Authors:  Benjamin S Goldberg; Margaret E Ackerman
Journal:  Immunol Cell Biol       Date:  2020-04-06       Impact factor: 5.126

Review 10.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.